Ribociclib
Other names:LEE011
CAS NO.: 1256963-02-6
MF: C22H29ClN8
CAS NO.: 1256963-02-6
MF: C22H29ClN8
API233
Quantity
![]()

Ribociclib is a kinase inhibitor used to treat HR+, HER2- advanced or metastatic breast cancer.
![]()
Kisqali (ribociclib) is a selective cyclin-dependent kinase inhibitor,
a class of drugs that help slow the progression of cancer by inhibiting two proteins called cyclin-dependent kinase 4 and 6 (CDK4/6).
These proteins, when over-activated, can enable cancer cells to grow and divide too quickly.
Targeting CDK4/6 with enhanced precision may play a role in ensuring that cancer cells do not continue to replicate uncontrollably.



